Genetic Disruption of Myostatin Reduces the Development of Proatherogenic Dyslipidemia and Atherogenic Lesions in LDLR Null Mice

Diabetes - United States
doi 10.2337/db09-0349
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Ces3/TGH Deficiency Improves Dyslipidemia and Reduces Atherosclerosis in LDLR-/- Mice

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2012English

Atherogenic Dyslipidemia in Diabetic Nephropathy: Lipoprotein (A), Lipid Ratios and Atherogenic Index

International Journal of Research in Medical Sciences
2013English

The Effect of Caloric Restriction on the Forelimb Skeletal Muscle Fibers of the Hypertrophic Myostatin Null Mice

Acta Histochemica
MedicineHistologyCell Biology
2017English

Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention

Lipids
Organic ChemistryBiochemistryCell Biology
2010English

Reduced Apoptosis and Plaque Necrosis in Advanced Atherosclerotic Lesions of Apoe−/− and Ldlr−/− Mice Lacking CHOP

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2009English

Involvement of Vascular Endothelial Cells in the Anti-Atherogenic Effects of Liraglutide in Diabetic Apolipoprotein E-Null Mice

The Showa University Journal of Medical Sciences
2019English

Deletion of LOX-1 Reduces Atherogenesis in LDLR Knockout Mice Fed High Cholesterol Diet

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2007English

Atherogenic Dyslipidemia and Residual Vascular Risk in Practice of Family Doctor

Medicinski Arhiv
Medicine
2015English

Macrophage-Specific Transgenic Expression of Cholesteryl Ester Hydrolase Significantly Reduces Atherosclerosis and Lesion Necrosis in Ldlr–/– Mice

Journal of Clinical Investigation
Medicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy